Dapagliflozin in Respiratory Failure in Patients With COVID-19
Clinical trial NCT04350593 · COMPLETED
Trial details
- NCT number
- NCT04350593
- Sponsor
- Saint Luke's Health System
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-22
- Primary completion
- 2021-03-31
- Enrollment
- 1250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.